Phase III study of abicipar in patients with Diabetic macular edema (DME)

Trial Profile

Phase III study of abicipar in patients with Diabetic macular edema (DME)

Planning
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2018

At a glance

  • Drugs Abicipar pegol (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Feb 2018 According to a Molecular Partners AG media release, company expects to initiate this trial in H2 2018.
    • 02 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top